Clinical Trial Search Results

274 studies were found about Cancer, Cancer and HIV - All Trials
Filter Results: All Studies Studies seeking new volunteers Studies with results

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Langerhans Cell Histiocytosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Aggressive NK-cell Leukemia; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Malignancies; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Clear Cell Renal Cell Carcinoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV Infection; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Mast Cell Leukemia; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Myeloid/NK-cell Acute Leukemia; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Osteolytic Lesions of Multiple Myeloma; Peripheral T-cell Lymphoma; Plasma Cell Neoplasm; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Renal Cell Cancer; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Stage IV Renal Cell Cancer; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia

NCT ID: NCT00890747

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; HIV Infection; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Meningeal Chronic Myelogenous Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Lymphoma; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific; Waldenstrom Macroglobulinemia

NCT ID: NCT00112593

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Condition: To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT; To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

NCT ID: NCT01546376

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; HIV-associated Hodgkin Lymphoma; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Secondary Myelodysplastic Syndromes

NCT ID: NCT00968630

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Condition: HIV Infection; HIV-associated Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma

NCT ID: NCT01771107

Screening for HIV-Associated Anal Cancer

Condition: HIV Infections; Anal Cancer; Anal Dysplasia; Papillomavirus Infections

NCT ID: NCT00188292

High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk

Condition: HIV-related Lymphoma; HIV Infections

NCT ID: NCT01045889

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Condition: Anus Neoplasms; HIV Infections

NCT ID: NCT00428285

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

Condition: HIV Infections; Anus Neoplasms

NCT ID: NCT00000764

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

Condition: Hematologic Neoplasm; HIV Infection

NCT ID: NCT00005785

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Condition: HIV; Burkitt's Lymphoma

NCT ID: NCT01516593

Chemotherapy for Lung Cancer in HIV-positive Patients

Condition: Non-small Cell Lung Cancer; Hiv-positive

NCT ID: NCT01296113

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Condition: HIV Infection; Recurrent Anal Cancer; Recurrent Breast Cancer; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Anal Cancer; Stage IV Breast Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT01249443

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Condition: HIV Infections; Diffuse Large B Cell Lymphoma

NCT ID: NCT00466258

Evaluation and Natural History of Children With Cancer and AIDS

Condition: Acquired Immunodeficiency Syndrome; Cancer; HIV Infections; Leukemia; Lymphoma

NCT ID: NCT00001424

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

Condition: Hiv Infection; Lung Cancer

NCT ID: NCT01207986

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers

Condition: HIV Infections; AIDS; Lung Cancer; Tobacco Addiction; Drug Addiction

NCT ID: NCT00491335

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Condition: Cervical Cancer; Acquired Immunodeficiency Syndrome

NCT ID: NCT01590017

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Condition: Hepatitis; HIV; Liver Cancer

NCT ID: NCT01350648

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Condition: Acquired Immunodeficiency Syndrome; Alcoholism; HIV Infection; Neoplasm; Smoking

NCT ID: NCT00001500

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I AIDS-related Lymphoma; Stage II AIDS-related Lymphoma; Stage III AIDS-related Lymphoma; Stage IV AIDS-related Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia

NCT ID: NCT01769911

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Condition: AIDS Related Lymphoma; HIV Infection

NCT ID: NCT00006436

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Condition: Anal Cancer; HIV Infections

NCT ID: NCT00666107

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Condition: Acquired Immunodeficiency Syndrome; Kaposi's Sarcoma; Leukemia; Lymphoma; Tumor Virus Infection; HIV Infections

NCT ID: NCT00001560

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

Condition: Adult Grade III Lymphomatoid Granulomatosis; AIDS-related Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; HIV Infection; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma

NCT ID: NCT01193842

Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00002221

Evaluation of Brain Lesions in HIV-Infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Condition: HIV Infections; Lymphoma, AIDS-Related

NCT ID: NCT00226304

Anal HPV Infection and Abnormal Cytology in HIV-infected Women

Condition: Cervical Cancer Screening; HIV Infections

NCT ID: NCT00933140

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Condition: HIV Infections; Lymphoma, Non-Hodgkin

NCT ID: NCT00432419

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00002003

A Study of Anal Cancer Development in HIV Infected People

Condition: HIV Infections; Anus Neoplasms

NCT ID: NCT00107679

Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Condition: HIV Infection; Kaposi's Sarcoma

NCT ID: NCT00006518

Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men

Condition: HIV Infections; Papillomavirus Infections; Anal Intraepithelial Neoplasia

NCT ID: NCT00365729

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

Condition: HIV Infections; Cancer, Second Primary

NCT ID: NCT00517803

Molecular Biology of Anal Cancer in HIV-Positive Patients

Condition: Carcinoma; HIV Infections

NCT ID: NCT00952874

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

Condition: Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections

NCT ID: NCT00001295

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Condition: Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections

NCT ID: NCT00001503

Allogeneic Transplant in HIV Patients (BMT CTN 0903)

Condition: Leukemia; Lymphoma; HIV

NCT ID: NCT01410344

A Study of Patients With AIDS Syndrome

Condition: Sarcoma, Kaposi; Lymphoma, Non-Hodgkin; HIV Infections; Lymphoma, AIDS-Related

NCT ID: NCT00001120

Autologous Transplant in HIV Patients (BMT CTN 0803)

Condition: Lymphoma; HIV

NCT ID: NCT01141712

A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00002284

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Condition: HIV; Cancer

NCT ID: NCT01205581

Screening for Lung Cancer in the HIV Patient

Condition: Lung Cancer in the HIV Patient

NCT ID: NCT01748136

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Condition: AIDS-Related Primary Central Nervous System Lymphoma; HIV

NCT ID: NCT00267865

Anal Cancer Screening Study

Condition: HIV Infections; Papillomavirus Infections; Anus Neoplasms

NCT ID: NCT00914537

A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00002348

Cohort of HIV Associated Lymphomas

Condition: HIV Infection

NCT ID: NCT01164436

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma

Condition: HIV; Lymphoma

NCT ID: NCT01330342

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Condition: Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition

NCT ID: NCT01209325

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00000723

Prospective Study on HIV-related Hodgkin Lymphoma

Condition: HIV-associated Hodgkin Lymphoma

NCT ID: NCT01468740

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Condition: Cervical Cancer; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00667563

Screening Patients for NCI Protocol Eligibility

Condition: Cancer; HIV Infection; Skin Disease

NCT ID: NCT00026754

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Condition: Lymphoma, AIDS Related; HIV Infections

NCT ID: NCT00799136

High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma

Condition: AIDS-Related Lymphoma; HIV Infections

NCT ID: NCT00858793

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00000801

Cryotherapy vs. LEEP to Treat CIN2/3 Among HIV-positive Women

Condition: Cervical Intraepithelial Neoplasia

NCT ID: NCT01298596

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00000689

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Condition: HIV Infections; Cancer; Pain

NCT ID: NCT00002160

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors

Condition: AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV-associated Hodgkin Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Grade I Lymphomatoid Granulomatosis; Recurrent Grade II Lymphomatoid Granulomatosis; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT01326702

Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment

Condition: AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; HIV-associated Hodgkin Lymphoma; Leptomeningeal Metastases; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Medulloblastoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00005811

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001116

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002262

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00000703

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00000658

A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women

Condition: Cancer Prevention; Cervix

NCT ID: NCT01605656

Psychological Benefits of a Normalized Camping Experience for Children With Cancer

Condition: HIV Infection; Neoplasm

NCT ID: NCT00001186

A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines

Condition: HIV Infections; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin

NCT ID: NCT00001571

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Condition: Lymphoma; Nonneoplastic Condition

NCT ID: NCT01319526

Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

Condition: HIV Infections; Central Nervous System Neoplasms; Neurofibromatosis 1

NCT ID: NCT01445314

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

Condition: HIV-1 Infection; Cancer; Immunosuppression

NCT ID: NCT01017172

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females

Condition: HPV-16/18 Infections; Cervical Neoplasia

NCT ID: NCT00586339

The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study

Condition: Cancer; HIV Infections

NCT ID: NCT00824278

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

Condition: Sarcoma, Kaposi; HIV Infections; Lymphoproliferative Disorders

NCT ID: NCT00002153

Studying Genes in Women With Hepatitis C Virus, Hepatitis B Virus, Human Papillomavirus, and/or HIV Infection

Condition: Liver Cancer; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00897689

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

Condition: HIV Infection; Rheumatic Disease; Cancer; Transplant; Pediatrics

NCT ID: NCT01022905

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin’s Lymphoma

Condition: AIDS Related Lymphoma

NCT ID: NCT00126243

Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma

Condition: AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma

NCT ID: NCT00022555

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

Condition: HIV Infections

NCT ID: NCT00000646

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

Condition: Lymphoma

NCT ID: NCT00003262

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Condition: Neoplasms

NCT ID: NCT01445145

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Condition: AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Stage III AIDS-related Lymphoma; Stage IV AIDS-related Lymphoma

NCT ID: NCT01775475

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Condition: Aids-related Malignancies; Lymphoma; Precancerous Condition; Sarcoma

NCT ID: NCT00695422

Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Condition: AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma

NCT ID: NCT00049036

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Condition: Lymphoma

NCT ID: NCT00641381

Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women

Condition: Cervical Dysplasia in HIV Positive Women

NCT ID: NCT01723956

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

Condition: HIV Infections; Cervix, Dysplasia

NCT ID: NCT00000758

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Condition: Acquired Immunodeficiency Syndrome; HIV Infection

NCT ID: NCT00001475

A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex

Condition: HIV Infections

NCT ID: NCT00001004

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Condition: Neoplasms, Squamous Cell; Papillomavirus Infections

NCT ID: NCT01709448

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Condition: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma; Nonneoplastic Condition

NCT ID: NCT01567722

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

Condition: HIV Infections

NCT ID: NCT00205231

Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

Condition: Anal Cancer; Neoplasm of Uncertain Malignant Potential; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT01164722

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Condition: Kaposi's Sarcoma; HIV Infections; HIV Seronegativity

NCT ID: NCT00055237

HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study

Condition: Cervical Cancer

NCT ID: NCT01792973

Effects of Potent Antiretroviral Therapy on Kaposi's Sarcoma

Condition: HIV Seropositivity; Kaposi's Sarcoma; HIV Infections

NCT ID: NCT00006171

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Condition: Leukemia; Lymphoma

NCT ID: NCT00003435

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

Condition: HIV Infections; Cervix, Dysplasia

NCT ID: NCT00001073

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Condition: Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia

NCT ID: NCT01076543

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002366

Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens

Condition: Alcoholism; HIV Infection; Homosexuality; Kaposi's Sarcoma

NCT ID: NCT00001294

Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma

Condition: Lymphoma

NCT ID: NCT00003261

Multidisciplinary Inpatient Palliative Care Intervention

Condition: Cerebrovascular Accident; Cancer; Coronary Arteriosclerosis; Heart Failure, Congestive; Diabetes Mellitus; Acquired Immunodeficiency Syndrome; Failure to Thrive; Pulmonary Disease, Chronic Obstructive; Dementia; Kidney Failure, Chronic; Pneumonia; Liver Failure; Renal Failure; Respiratory Failure; Stroke

NCT ID: NCT00325611

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002226

Interferon Alfa in Treating Children With HIV-Related Cancer

Condition: Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00002621

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Condition: HIV Infections; Hodgkin's Disease

NCT ID: NCT00000626

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Condition: Lymphoma; Sarcoma

NCT ID: NCT00002936

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00066430

SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Condition: Anal Cancer

NCT ID: NCT00052897

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002185

Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer

Condition: Anal Cancer

NCT ID: NCT00324415

A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002136

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002137

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002138

A Study of Tecogalan Sodium

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002342

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00005931

Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002167

Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00032149

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00550589

Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00031902

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Condition: Lymphoma

NCT ID: NCT00392834

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00002905

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00003595

Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00003575

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00003942

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

Condition: AIDS Related Lymphoma; Non Hodgkin's Lymphoma

NCT ID: NCT00001563

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00002578

Twins Study of Gene Therapy for HIV Infection

Condition: Acquired Immunodeficiency Syndrome; HIV Infection; Kaposi's Sarcoma

NCT ID: NCT00001535

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Condition: HIV; AIDS; Kaposi's Sarcoma; Human Herpesvirus 8

NCT ID: NCT00380770

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Condition: Human Papillomavirus Infection

NCT ID: NCT01031069

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Condition: HIV Infections; Papilloma

NCT ID: NCT00006444

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Condition: HIV Infections

NCT ID: NCT00000994

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Condition: Human Immunodeficiency Virus; Human Papillomavirus- 6, 11, 16, 18; Adolescent; Papillomavirus Vaccines

NCT ID: NCT00798265

Treatment of Oral Warts in HIV+ Patients

Condition: Papillomatosis; HIV Infections

NCT ID: NCT00454181

A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002314

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002093

A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma

Condition: AIDS-related Kaposi Sarcoma; HIV Infection

NCT ID: NCT00020683

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Condition: HIV; Hepatitis B; Hepatitis C; Carcinoma, Hepatocellular; AIDS

NCT ID: NCT01790633

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV

Condition: Anal Dysplasia; Human Papilloma Virus; HIV

NCT ID: NCT01663558

KSHV Infection in Blood Donors From Texas

Condition: Blood Donors; Acquired Immunodeficiency Syndrome; Blood Transfusion; Herpesvirus, Kaposi Sarcoma-Associated; Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00006310

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Condition: AIDS-related Kaposi Sarcoma; HIV Infection; Recurrent Kaposi Sarcoma

NCT ID: NCT01016730

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002105

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000807

A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002212

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00001113

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00001114

A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002318

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002319

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000725

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002131

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002147

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000954

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00001059

Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002259

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000660

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000763

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000769

A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000681

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000687

A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000987

Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002189

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000694

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000695

A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000996

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Undifferentiated Leukemia; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Gastrointestinal Stromal Tumor; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Meningeal Chronic Myelogenous Leukemia; Monoclonal Gammopathy of Undetermined Significance; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Polycythemia Vera; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Non-Hodgkin Lymphoma; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Unspecified Adult Solid Tumor, Protocol Specific; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia

NCT ID: NCT00025415

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Condition: AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Chondrosarcoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Osteosarcoma; Nodal Marginal Zone B-cell Lymphoma; Ovarian Sarcoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Osteosarcoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Uterine Sarcoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult Soft Tissue Sarcoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Stage IV Uterine Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00004241

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Condition: AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00077155

Oral Human Papillomavirus Infection in HIV-Infected Men

Condition: Papillomavirus Infections; HIV Infections

NCT ID: NCT00421486

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Condition: AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00003970

Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients

Condition: Flat Warts (Diagnosis); HIV Infections

NCT ID: NCT01289171

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

Condition: HIV Infection

NCT ID: NCT01492842

Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer

Condition: Lymphoma

NCT ID: NCT00058045

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00569985

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Condition: AIDS-related Lymphoma; Adult Non-Hodgkin's Lymphoma; Anaplastic Large Cell Lymphoma

NCT ID: NCT00310128

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

Condition: AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma

NCT ID: NCT00036855

The Role of Genital Warts in HIV Acquisition in Peru

Condition: Anogenital Warts; HIV

NCT ID: NCT01387412

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Condition: Leukoplakia, Hairy; HIV Infections

NCT ID: NCT00002026

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002439

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002445

Anti-Retrovirals for Kaposi's Sarcoma

Condition: Kaposi's Sarcoma; HIV Infections

NCT ID: NCT00444379

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002188

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

Condition: HIV-1 Infection; Kaposi's Sarcoma

NCT ID: NCT01352117

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

Condition: Lymphoma

NCT ID: NCT00392990

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: AIDS-related Kaposi Sarcoma; Recurrent Kaposi Sarcoma

NCT ID: NCT00064142

AIDS and Cancer Specimen Bank (ACSB)

Condition: Kaposi's Sarcoma AIDS Related; Kaposi's Sarcoma Classical; Non-Hodgkin's Lymphoma; HEMATOPOIETIC SYSTEM; Cancer; AIDS

NCT ID: NCT00587912

EuroSIDA As An External Comparator To MOTIVATE Trials

Condition: HIV; AIDS

NCT ID: NCT01329783

Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe

Condition: Kaposi Sarcoma (KS); HIV

NCT ID: NCT01764360

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Condition: Kaposi's Sarcoma

NCT ID: NCT01276236

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT00686842

Lenalidomide in Kaposi Disease Associated With HIV Infection

Condition: HIV Infection Associated Kaposi Disease

NCT ID: NCT01282047

Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men

Condition: Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00919997

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Condition: Cervical Cancer; Precancerous Condition

NCT ID: NCT00458562

Pomalidomide for Kaposi Sarcoma in People With or Without HIV

Condition: Sarcoma, Kaposi

NCT ID: NCT01495598

The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata

Condition: HIV Positive; Anal Condylomata; Anal Warts; HIV Infections

NCT ID: NCT00941889

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00450320

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00019123

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00006222

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00090987

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00024024

Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003419

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Condition: Pancreatic Neoplasms

NCT ID: NCT01086332

Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community

Condition: HIV Infections; Sexually Transmitted Diseases; Papillomavirus Infections; Genital Herpes; Gonorrhea; Chlamydia Infections; Syphilis; Bacterial Vaginosis

NCT ID: NCT00124878

Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer

Condition: Adenocarcinoma of the Pancreas; Pancreatic Cancer; Stage III Pancreatic Cancer

NCT ID: NCT01068327

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Condition: Carcinoma, Adenoid Cystic; Head and Neck Neoplasms

NCT ID: NCT01065844

The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients

Condition: HIV Infections; Condyloma Acuminata

NCT ID: NCT00002327

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.

Condition: 1- Women; 2- HIV Infection; 3- Followed in West Indies and French Guiana for His Infection; 4- Acceptance of the Use of Nadis® Medical Files

NCT ID: NCT01226368

Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women

Condition: HIV Infections

NCT ID: NCT01461096

A Study of Selumetinib in Patients With Kaposi's Sarcoma

Condition: AIDS-related Kaposi's Sarcoma

NCT ID: NCT01752569

Radical Lung Radiotherapy Plus Nelfinavir

Condition: Lung Cancer

NCT ID: NCT01447589

Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Condition: Lung Cancer

NCT ID: NCT00276588

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Condition: AIDS-related Kaposi Sarcoma; Recurrent Kaposi Sarcoma

NCT ID: NCT01057121

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Condition: Lymphoma

NCT ID: NCT00006264

Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer

Condition: Carcinoma, Non-Small-Cell Lung

NCT ID: NCT00791336

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Condition: Warts

NCT ID: NCT00761371

Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

Condition: HPV Infection; HIV Infection; Syphilis

NCT ID: NCT01300689

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

Condition: Candidiasis, Oral; Thrush; Candidiasis

NCT ID: NCT00612963

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

Condition: Classical Kaposi's Sarcoma

NCT ID: NCT00362310

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT01067690

Typing of Human Papilloma Virus (HPV) From Female Genital Warts

Condition: Genital Warts; Human Papilloma Virus

NCT ID: NCT01192282

Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma

Condition: AIDS-related Kaposi Sarcoma

NCT ID: NCT00003350

Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM

Condition: HIV Testing; Linkage to Care

NCT ID: NCT01637324

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Condition: HIV Infections; HIV Wasting Syndrome; Lipodystrophy

NCT ID: NCT00006064

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; Burning Mouth Syndrome; HIV Infection

NCT ID: NCT00001524

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

Condition: HIV Infections

NCT ID: NCT00002059

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00000860

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Condition: Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00003207

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Condition: Mycoses; HIV Infections

NCT ID: NCT00002277

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Condition: Infection; Precancerous Condition

NCT ID: NCT00513526

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Condition: Burkitt Lymphoma; Diffuse Large B-cell Lymphoma, c-MYC Positive

NCT ID: NCT01092182

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Condition: Kaposi´s Sarcoma

NCT ID: NCT01296815

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Condition: Sexually Transmitted Infections; HIV Infections

NCT ID: NCT01043081

Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma

Condition: Lymphoma; Nonneoplastic Condition

NCT ID: NCT00981097

Biomarkers to Detect Anal Intraepithelial Neoplasia in Thai Men Who Have Sex With Men

Condition: Anal Intraepithelial Neoplasia

NCT ID: NCT01637298

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00427414

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

Condition: Sarcoma

NCT ID: NCT00019240

Prospective Study of Lymphoproliferative Diseases

Condition: Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma

NCT ID: NCT01704742

HPV in Adolescents

Condition: HPV Infection; Cervical/Anal Dysplasia

NCT ID: NCT01788852

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Epidemic Kaposi's Sarcoma; Recurrent Kaposi's Sarcoma

NCT ID: NCT00019188

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Condition: Cryptococcosis

NCT ID: NCT00001701

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Condition: Blastomycosis

NCT ID: NCT00001702

Human Papilloma Virus (HPV) Type-Specific Antibody

Condition: Papilloma Virus, Human

NCT ID: NCT01206556

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Condition: Hodgkin Lymphoma; Non Hodgkin Lymphoma; Kaposi's Sarcoma; Gastric Cancer; Nasopharyngeal Cancer

NCT ID: NCT00982449

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Condition: Lung Cancer; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00734890

Collecting and Storing Blood Samples From Patients With Cancer

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00900120

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00750009

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Condition: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Methemoglobinemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nonmalignant Neoplasm

NCT ID: NCT00993694

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Condition: Brain and Central Nervous System Tumors; Breast Cancer; Colorectal Cancer; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT01158274

Studying Fentanyl in Patients With Cancer

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00899951

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Depression; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Psychosocial Effects of Cancer and Its Treatment; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00770419

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Condition: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Pain; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00726830

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Condition: Brain and Central Nervous System Tumors; Carcinoma of Unknown Primary; Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00112619

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Condition: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neurotoxicity; Pain; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00516503

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Condition: Leukemia; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific

NCT ID: NCT00002663

The Second Multicenter Hemophilia Cohort Study

Condition: Liver Decompensation; Hepatocellular Carcinoma; Non-Hodgkin Lymphoma

NCT ID: NCT00341705

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Condition: Cancer

NCT ID: NCT01316744

A Phase I Trial of Nelfinavir (Viracept(Registered Trademark)) in Adults With Solid Tumors

Condition: Solid Tumors

NCT ID: NCT01445106

Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men

Condition: Anal Cancer; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00955591

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00345865

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00005824

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00024128

HIV Indicator Diseases Survey Across Europe - UK Arm

Condition: HIV; AIDS; Indicator Diseases/Indicator Conditions

NCT ID: NCT01196468

Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease

Condition: Lymphoma

NCT ID: NCT00003114

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003008

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003720

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00005042

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00020449

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00002985

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

Condition: AIDS-related Kaposi Sarcoma; Classic Kaposi Sarcoma

NCT ID: NCT00521092

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT00287495

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi's Sarcoma

Condition: Sarcoma, Kaposi

NCT ID: NCT00923936

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Condition: Castleman Disease; Castleman's Disease; Giant Lymph Node Hyperplasia

NCT ID: NCT01441063

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman's Disease With Correlates of Disease Activity

Condition: Giant Lymph Node Hyperplasia

NCT ID: NCT00092222

In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients

Condition: Cell Function

NCT ID: NCT00342485